In vivo Efficacy of a Dry Powder Formulation of Ciprofloxacin-Copper Complex in a Chronic Lung Infection Model of Bioluminescent Pseudomonas aeruginosa
Autor: | Frederic Tewes, Hugh D. C. Smyth, Tania F. Bahamondez-Canas, Daniel Moraga-Espinoza, Alan B. Watts |
---|---|
Přispěvatelé: | Pharmacologie des anti-infectieux (PHAR), Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM), Division of Molecular Pharmaceutics and Drug Delivery [Austin, TX, USA] (College of Pharmacy), The University of Texas at Austin, Universidad de Valparaiso [Chile], Tewes, Frederic |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
food.ingredient Chemistry Pharmaceutical Pharmaceutical Science 02 engineering and technology medicine.disease_cause 030226 pharmacology & pharmacy Permeability Microbiology Rats Sprague-Dawley 03 medical and health sciences Pulmonary Absorption 0302 clinical medicine food Ciprofloxacin In vivo Administration Inhalation medicine Animals Agar Pseudomonas Infections Lung Respiratory Tract Infections [SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology Inhalation exposure Chemistry Pseudomonas aeruginosa Dry Powder Inhalers General Medicine [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences 021001 nanoscience & nanotechnology Antimicrobial Anti-Bacterial Agents Rats 3. Good health [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences Disease Models Animal [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology Biofilms Spray drying Powders 0210 nano-technology Copper Biotechnology medicine.drug |
Zdroj: | European Journal of Pharmaceutics and Biopharmaceutics European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2020, 152, pp.201-217. ⟨10.1016/j.ejpb.2020.05.014⟩ |
ISSN: | 0939-6411 |
DOI: | 10.1016/j.ejpb.2020.05.014⟩ |
Popis: | International audience; A significant limitation of locally delivered treatments for chronic pulmonary infections is often the short residence time within the airways. Ciprofloxacin (CIP), for example, undergoes rapid absorption from the airway lumen. Previously, we demonstrated that the complexation of CIP with copper (CIP-Cu) reduces its apparent epithelial permeability and pulmonary absorption rate without affecting antimicrobial activity against Pseudomonas aeruginosa grown planktonically or as biofilms. This study aimed to evaluate the in vivo efficacy of CIP-Cu, prepared as a dry powder, in a chronic lung infection model. The powders were prepared by jet milling (CIP-HCl) and by spray drying (CIP-Cu). A bioluminescent strain of P. aeruginosa (PAO1::p16Slux) was used to prepare bacteria-loaded agar beads that were inoculated intratracheally to rats. The dynamics of the infection were monitored using luminometry. The bacteria/beads ratio was optimized to allow the highest luminescence signal and animal survival for 8 days. The efficacy of the treatment was evaluated by luminometry in addition to the end-point (Day 8) where colony counting was performed after lung harvesting. Luminescent P. aeruginosa entrapped in agar beads were useful to monitor the spatial development of the chronic lung infection in rats. The rats were treated with the dry powders in a nose-only inhalation exposure system (NOIES). CIP-Cu and CIP-HCl powders showed similar aerodynamic properties and comparable CIP lung deposition. However, treatment with CIP-Cu significantly (p |
Databáze: | OpenAIRE |
Externí odkaz: |